Melatonin and painful gynecomastia

Neurology

Volumn 53, Issue 2, 1999, Pages 435-436

  De Bleecker, J L ^a   Lamont, B H ^a   Verstraete, A G ^a   Schelfhout, V J ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; ANTIOXIDANT; FREE RADICAL; MELATONIN; TESTOSTERONE;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CASE REPORT; DRUG EFFICACY; ENZYME ASSAY; GYNECOMASTIA; HORMONE DETERMINATION; HUMAN; MALE; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS;

EID: 0033595204     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.53.2.435     Document Type: Article

References (7)

1. Penev PD, Zee PC. Melatonin: a clinical perspective. Ann Neurol 1997; 42:545-553.
2. Cagnoli CM, Atabay C, Kharlamova E, Manev H. Melatonin protects neurons from singlet oxygen-induced apoptosis. J Pineal Res 1995;18: 222-226.
3. Bresinski A. Mechanisms of disease: melatonin in humans. N Engl J Med 1997;336:186-195.
4. Terzolo M, Piovesan A, Puligheddu B, et al. Effects of long-term, low-dose, time-specified melatonin administration on endocrine and cardiovascular variables in adult men. J Pineal Res 1990;9:113-124.
5. Quality Standards Subcommittee of the American Academy of Neurology. Practice advisory on the treatment of amyotrophic lateral sclerosis with riluzole: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 1997;49:657-659.
6. Waldhauser F, Lieberman HR, Lynch HJ, et al. A pharmacological dose of melatonin increases PRL levels in males without altering those of GH, LH, FSH, TSH, testosterone or cortisol. Neuroendocrinology 1987;46: 125-130.
7. Rodriguez-Rigau LJ, Smith KD. Gynecomastia. In: De Groot LJ, ed. Endocrinology. 2nd ed. London: WB Saunders, 1989:2207-2210.